Healthcare (SH:603313) Sou Hu Cai Jing·2025-07-10 05:04Core Viewpoint - Dream百合 reported a revenue of 8.449 billion yuan for 2024, reflecting a year-on-year growth of 5.94%, but faced a net loss of 151 million yuan, a significant decline of 242.04% compared to the previous year [3]. Financial Performance - In Q1 2025, Dream百合's revenue increased to 2.043 billion yuan, marking a year-on-year rise of 12.31%, with a net profit of 58.72 million yuan, up 196.22% year-on-year [4][5]. - For the fiscal year ending December 31, 2024, the company reported a net profit of -161 million yuan, a decrease of 242.04%, and an operating income of 8.449 billion yuan [5]. Legal Issues - Dream百合 has been involved in legal disputes with its U.S. subsidiary and clients, including a recent lawsuit against CVB for 42.6 million USD in receivables due to poor repayment performance [4]. - The company reached a settlement regarding a long-standing lawsuit with CHINA BEDS DIRECT, LLC, which has been ongoing for over a decade [3].